Artykuły w czasopismach na temat „Cardiovascular damage”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Cardiovascular damage”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Collinson, Paul O., and David C. Gaze. "Biomarkers of Cardiovascular Damage." Medical Principles and Practice 16, no. 4 (2007): 247–61. http://dx.doi.org/10.1159/000102146.
Pełny tekst źródłaMayhew, Maren S. "Aspirin for Preventing Cardiovascular Damage." Journal for Nurse Practitioners 6, no. 2 (2010): 147–48. http://dx.doi.org/10.1016/j.nurpra.2009.12.004.
Pełny tekst źródłaFunder, John W. "Mineralocorticoid Receptors and Cardiovascular Damage." Hypertension 47, no. 4 (2006): 634–35. http://dx.doi.org/10.1161/01.hyp.0000203732.03784.3b.
Pełny tekst źródłaShakariants, G. A. Shakariants, V. Yu Kaplunova Kaplunova, I. S. Chekneva Chekneva, E. V. Privalova Privalova, and Yu N. Belenkov Belenkov. "Postradiation Damage of the Cardiovascular System." Kardiologiia 12_2014 (December 17, 2014): 97–104. http://dx.doi.org/10.18565/cardio.2014.12.97-104.
Pełny tekst źródłaKrüger, Thilo, Stephan Oelenberg, Nadine Kaesler, et al. "Warfarin Induces Cardiovascular Damage in Mice." Arteriosclerosis, Thrombosis, and Vascular Biology 33, no. 11 (2013): 2618–24. http://dx.doi.org/10.1161/atvbaha.113.302244.
Pełny tekst źródłavan Schooten, Frederik J., Ad M. Knaapen, and Alberto Izzotti. "DNA damage, mutagenesis and cardiovascular disease." Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 621, no. 1-2 (2007): 1–4. http://dx.doi.org/10.1016/j.mrfmmm.2007.02.006.
Pełny tekst źródłaLee, S. "Oxidative DNA Damage and Cardiovascular Disease." Trends in Cardiovascular Medicine 11, no. 3-4 (2001): 148–55. http://dx.doi.org/10.1016/s1050-1738(01)00094-9.
Pełny tekst źródłaShukla, Praphulla C., Krishna K. Singh, Bobby Yanagawa, Hwee Teoh, and Subodh Verma. "DNA damage repair and cardiovascular diseases." Canadian Journal of Cardiology 26 (March 2010): 13A—16A. http://dx.doi.org/10.1016/s0828-282x(10)71055-2.
Pełny tekst źródłaRichardson, Kelly, Gregory Engel, Takuya Yamazaki, Sung Chun, and Victor F. Froelicher. "Electrocardiographic damage scores and cardiovascular mortality." American Heart Journal 149, no. 3 (2005): 458–63. http://dx.doi.org/10.1016/j.ahj.2004.06.025.
Pełny tekst źródłaRichardson, K., G. Engel, and T. Yamazaki. "Electrocardiographic Damage Scores and Cardiovascular Mortality." ACC Current Journal Review 14, no. 12 (2005): 22. http://dx.doi.org/10.1016/j.accreview.2005.11.035.
Pełny tekst źródłaKumar, Naresh. "Cardiovascular Manifestations of SARS CoV-2: A Review." Journal of Advanced Research in Medicine 07, no. 02 (2020): 1–10. http://dx.doi.org/10.24321/2349.7181.202005.
Pełny tekst źródłaBuffolo, Fabrizio, Martina Tetti, Paolo Mulatero, and Silvia Monticone. "Aldosterone as a Mediator of Cardiovascular Damage." Hypertension 79, no. 9 (2022): 1899–911. http://dx.doi.org/10.1161/hypertensionaha.122.17964.
Pełny tekst źródłaQuan, Yue, Yanguo Xin, Geer Tian, Junteng Zhou, and Xiaojing Liu. "Mitochondrial ROS-Modulated mtDNA: A Potential Target for Cardiac Aging." Oxidative Medicine and Cellular Longevity 2020 (March 27, 2020): 1–11. http://dx.doi.org/10.1155/2020/9423593.
Pełny tekst źródłaBaaj, Teim, Ahmed Abu-Awwad, Mircea Botoca, et al. "Biochemical and Paraclinical Evaluation of Organ Damage in Arterial Hypertension with Associated Chronic Kidney Disease." Revista de Chimie 71, no. 6 (2020): 194–204. http://dx.doi.org/10.37358/rc.20.6.8183.
Pełny tekst źródłaGutan, Inesa, Stela Dodu, Elena Panfile, et al. "Cardiovascular damage in patients with systemic scleroderma." Bulletin of the Academy of Sciences of Moldova. Medical Sciences 72, no. 1 (2022): 164–68. http://dx.doi.org/10.52692/1857-0011.2022.1-72.26.
Pełny tekst źródłaArmani, Chiara, Nicoletta Botto, Maria Grazia Andreassi, and Emilio Centaro. "Molecular Markers of Cardiovascular Damage in Hypertension." Current Pharmaceutical Design 19, no. 13 (2013): 2341–50. http://dx.doi.org/10.2174/1381612811319130002.
Pełny tekst źródłaCinza Sanjurgo, S., J. E. López Paz, A. Hermida Ameijeiras, et al. "ORGAN DAMAGE AND CARDIOVASCULAR PROGNOSIS IN HYPERTENSION." Journal of Hypertension 29 (June 2011): e256. http://dx.doi.org/10.1097/00004872-201106001-00717.
Pełny tekst źródłaZanchetti, Alberto. "Hypertension-related organ damage and cardiovascular risk." Journal of Hypertension 32, no. 11 (2014): 2107–8. http://dx.doi.org/10.1097/hjh.0000000000000388.
Pełny tekst źródłaLuft, Friedrich C. "Workshop: Mechanisms and Cardiovascular Damage in Hypertension." Hypertension 37, no. 2 (2001): 594–98. http://dx.doi.org/10.1161/01.hyp.37.2.594.
Pełny tekst źródłaSehestedt, Thomas, and Michael H. Olsen. "Subclinical organ damage and cardiovascular risk prediction." Blood Pressure 19, no. 3 (2010): 132–39. http://dx.doi.org/10.3109/08037051.2010.483054.
Pełny tekst źródłaMaxwell, S. R., R. J. Moots, and M. J. Kendall. "Corticosteroids: do they damage the cardiovascular system?" Postgraduate Medical Journal 70, no. 830 (1994): 863–70. http://dx.doi.org/10.1136/pgmj.70.830.863.
Pełny tekst źródłaShimosawa, Tatsuo, Yugo Shibagaki, Kotaro Ishibashi, et al. "Adrenomedullin, an Endogenous Peptide, Counteracts Cardiovascular Damage." Circulation 105, no. 1 (2002): 106–11. http://dx.doi.org/10.1161/hc0102.101399.
Pełny tekst źródłaCRUICKSHANK, J., and J. SMITH. "The beta-receptor, atheroma and cardiovascular damage." Pharmacology & Therapeutics 42, no. 3 (1989): 385–404. http://dx.doi.org/10.1016/0163-7258(89)90032-6.
Pełny tekst źródłaMatafonova, К. А., Е. N. Romanova, Е. М. Romanova, and D. V. Malko. "CARDIOVASCULAR SYSTEM DAMAGE DURING POST-COVID SYNDROME." Transbaikalian Medical Bulletin, no. 1 (May 18, 2024): 154–62. http://dx.doi.org/10.52485/19986173_2024_1_154.
Pełny tekst źródłaAltabás-González, Irene, Iñigo Rua-Figueroa, Coral Mouriño, et al. "Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis." Lupus Science & Medicine 11, no. 2 (2024): e001064. http://dx.doi.org/10.1136/lupus-2023-001064.
Pełny tekst źródłaSafari, Mohammad Reza, Mohsen Rezaee, and Saeid Amiri. "Comparing Plasma Fibrinogen,Homocysteine, Cardiac Troponin I, and C-Reactive Protein Levels Among Smokers and Non-smokers inHamadan Hospitals: A Case-Control Study." Avicenna journal of Care and Health in Operating Room 2, no. 2 (2024): 71–74. http://dx.doi.org/10.34172/ajchor.61.
Pełny tekst źródłaKorzh, O. M. "Damage to the cardiovascular system in COVID-19." Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2021, no. 1 (2021): 10–16. http://dx.doi.org/10.15407/internalmed2021.01.010.
Pełny tekst źródłaLeone, Aurelio. "Editorial (Hot Topic: Modifying Cardiovascular Risk Factors: New Markers of Cardiovascular Damage)." Current Pharmaceutical Design 19, no. 13 (2013): 2335–40. http://dx.doi.org/10.2174/1381612811319130001.
Pełny tekst źródłaKuan, WP, EK Li, and L.-S. Tam. "Lupus organ damage: what is damaged in Asian patients?" Lupus 19, no. 12 (2010): 1436–41. http://dx.doi.org/10.1177/0961203310370050.
Pełny tekst źródłaFedorovych, M., R. Khrustavka, D. Koval, A. Mykolenko, T. Golovata, and I. Smachylo. "MORPHOLOGICAL MANIFESTATIONS OF CARDIOVASCULAR AND NEUROLOGICAL COMPLICATIONS OF COVID-19." Sciences of Europe, no. 131 (December 27, 2023): 36–41. https://doi.org/10.5281/zenodo.10434512.
Pełny tekst źródłaDi Tomasso, Nora, Fabrizio Monaco, and Giovanni Landoni. "Renal protection in cardiovascular surgery." F1000Research 5 (March 11, 2016): 331. http://dx.doi.org/10.12688/f1000research.7348.1.
Pełny tekst źródłaLeone, Aurelio. "Biochemical Markers of Cardiovascular Damage from Tobacco Smoke." Current Pharmaceutical Design 11, no. 17 (2005): 2199–208. http://dx.doi.org/10.2174/1381612054367391.
Pełny tekst źródłaPillai, Ajay, and Barbara Lawson. "Coronavirus disease 2019 and cardiovascular diseases: collateral damage?" Current Opinion in Anaesthesiology 35, no. 1 (2021): 5–11. http://dx.doi.org/10.1097/aco.0000000000001076.
Pełny tekst źródłaKravtsiva, A. V., A. A. Gulyaeva, E. D. Golovanova, and K. V. Ayrapetov. "DAMAGE TO THE CARDIOVASCULAR SYSTEM IN COVID-19." Вестник Смоленской государственной медицинской академии 20, no. 4 (2021): 59–65. http://dx.doi.org/10.37903/vsgma.2021.4.8.
Pełny tekst źródłaBalykova, L. A., D. O. Vladimirov, A. V. Krasnopolskaya, O. M. Soldatov, N. V. Ivyanskaya, and N. V. Shchekina. "CARDIOVASCULAR SYSTEM DAMAGE IN CHILDREN WITH COVID-19." Pediatria. Journal named after G.N. Speransky 100, no. 5 (2021): 90–98. http://dx.doi.org/10.24110/0031-403x-2021-100-5-90-98.
Pełny tekst źródłaNadarajah, Ramesh, and Chris P. Gale. "Collateral cardiovascular damage during the COVID-19 pandemic." Nature Reviews Cardiology 19, no. 2 (2021): 81–82. http://dx.doi.org/10.1038/s41569-021-00661-x.
Pełny tekst źródłaMoguchaia, E. V., O. P. Rotar, M. A. Boyarinova, et al. "Long-term cardiovascular damage in Leningrad Siege survivors." "Arterial’naya Gipertenziya" ("Arterial Hypertension") 27, no. 2 (2021): 170–79. http://dx.doi.org/10.18705/1607-419x-2021-27-2-170-179.
Pełny tekst źródłaLiu, Ming, Man Han, and Xiao-Mei Leng. "Research progress in psoriatic arthritis-related cardiovascular damage." Chinese Medical Journal 133, no. 24 (2020): 3001–3. http://dx.doi.org/10.1097/cm9.0000000000001215.
Pełny tekst źródłaBader, Michael. "Molecular Interactions of Vasoactive Systems in Cardiovascular Damage." Journal of Cardiovascular Pharmacology 38 (November 2001): S7—S9. http://dx.doi.org/10.1097/00005344-200111002-00003.
Pełny tekst źródłaGuida, Lucio, Rita Iannuzzi, Marina Crivaro, et al. "Clinic-daytime blood pressure difference and cardiovascular damage." Journal of Hypertension 17, no. 3 (1999): 331–37. http://dx.doi.org/10.1097/00004872-199917030-00005.
Pełny tekst źródłaSalukhov, V. V. Salukhov, and B. V. Sagun Sagun. "Key aspects of cardiovascular damage in COVID-19." Pharmateca 9-10_2023 (November 17, 2023): 70–78. http://dx.doi.org/10.18565/pharmateca.2023.9-10.70-78.
Pełny tekst źródłaNAGATA, Daisuke, and Yasunobu HIRATA. "Molecular Mechanism of Cardiovascular Damage Induced by Aldosterone." YAKUGAKU ZASSHI 127, no. 9 (2007): 1339–46. http://dx.doi.org/10.1248/yakushi.127.1339.
Pełny tekst źródłaMatsumori, Akira. "Calcium channel blocker-induced protection against cardiovascular damage." International Journal of Cardiology 62 (December 1997): S39—S46. http://dx.doi.org/10.1016/s0167-5273(97)00240-4.
Pełny tekst źródłaWitte, K., A. Schnecko, T. Schmidt, C. Voll, B. Kränzlin, and B. Lemmer. "Cardiovascular risk, renal hypertensive damage, and effects of." General Pharmacology: The Vascular System 33, no. 5 (1999): 423–30. http://dx.doi.org/10.1016/s0306-3623(99)00037-3.
Pełny tekst źródłaLevin, A. "Prevalence of cardiovascular damage in early renal disease." Nephrology Dialysis Transplantation 16, suppl 2 (2001): 7–11. http://dx.doi.org/10.1093/ndt/16.suppl_2.7.
Pełny tekst źródłaGUIDA, L. "G8 White coat hypertension and early cardiovascular damage." American Journal of Hypertension 10, no. 4 (1997): 61A. http://dx.doi.org/10.1016/s0895-7061(97)88861-9.
Pełny tekst źródłaCingolani, Oscar H. "Cardiovascular Risks and Organ Damage in Secondary Hypertension." Endocrinology and Metabolism Clinics of North America 48, no. 4 (2019): 657–66. http://dx.doi.org/10.1016/j.ecl.2019.08.015.
Pełny tekst źródłaCollinson, Paul O., and David C. Gaze. "Biomarkers of Cardiovascular Damage and Dysfunction—An Overview." Heart, Lung and Circulation 16 (January 2007): S71—S82. http://dx.doi.org/10.1016/j.hlc.2007.05.006.
Pełny tekst źródłaLeone, A. "Cardiovascular damage from smoking: a fact or belief?" International Journal of Cardiology 38, no. 2 (1993): 113–17. http://dx.doi.org/10.1016/0167-5273(93)90169-h.
Pełny tekst źródłaSeriakova, I. Yu, S. O. Kramarov, V. V. Yevtushenko, et al. "Cardiovascular system damage in children with COVID-19." Modern pediatrics. Ukraine, no. 5(133) (September 28, 2023): 6–16. http://dx.doi.org/10.15574/sp.2023.133.6.
Pełny tekst źródła